Vaccines against various forms of cancer prime the immune system to attack.

Preliminary results from an Israel-based study suggest that one dose of the vaccine reduces infectiousness—a key factor in slowing virus spread.

An expert panel will present how synthetic biology accelerates the development of diagnostics, therapeutics, and the medicinal pipeline.

A preprint casts doubt on vaccine effectiveness in light of certain mutations in the 501Y.V2 variant that emerged from South Africa.

From new treatments to an investigation into the virus’s origins, here are some of the developments we can expect this year.

The majority of people experiencing anaphylaxis had a history of allergic reactions, a report by the agency finds.

The world was rocked by the COVID-19 pandemic this year, but researchers rose to all manner of challenges.

Researchers turn to familiar model animals, along with some fresh strategies, to develop countermeasures against SARS-CoV-2 and investigate the biology of infection.

Meet some of the people featured in the November 2020 issue of The Scientist.